Old Web
English
Sign In
Acemap
>
authorDetail
>
Iris Manor
Iris Manor
New York University
Psychology
Psychiatry
Metadoxine
Placebo
Clinical psychology
4
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
S.26.03 Metadoxine: a novel non-stimulant extended-release drug for treating ADHD
2012
European Neuropsychopharmacology
Iris Manor
Rachel Ben-Hayun
J. Aharon
D. Salomy
Abraham Weizman
Y. Danieli
Dalia Megiddo
Jeffrey H. Newcorn
Joseph Biederman
Lenard A. Adler
Show All
Source
Cite
Save
Citations (0)
The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: A double-blind placebo-controlled trial, followed by an open-label extension
2012
Iris Manor
Ayelet Magen
Daniella Keidar
S. Rosen
Hanan Tasker
Tzafra Cohen
Yael Richter
Daphna Zaaroor-Regev
Yair Manor
Abraham Weizman
Show All
Source
Cite
Save
Citations (3)
A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
2012
The Journal of Clinical Psychiatry
Iris Manor
Rachel Ben-Hayun
Judith Aharon-Peretz
Dana Salomy
Abraham Weizman
Yaron Daniely
Dalia Megiddo
Jeffrey H. Newcorn
Joseph Biederman
Lenard A. Adler
Show All
Source
Cite
Save
Citations (21)
P.1.c.055 Metadoxine:a novel 5HT-2B receptor antagonist with a possible therapeutic role in treating ADHD
2011
European Neuropsychopharmacology
Yaron Daniely
D. Reich
Dalia Megiddo
Iris Manor
Show All
Source
Cite
Save
Citations (1)
1